Project Grant R01GM165727
- Federal Grant Award Summary Duke University's Office of Research Administration received a $482,750 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. The award supports the development of computational methods for in-situ structure determination using cryo-electron tomography (cryo-ET), a technology that visualizes macromolecules in their...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $444,125 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026 through February 28, 2031. The award funds the development of advanced machine learning methods and bioinformatics software to analyze high-resolution, genome-wide spatial transcriptomics data. The project delivers three...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $737,152 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) on March 10, 2026. The award funds research through December 31, 2030, combining two ongoing NIGMS R01 projects focused on elucidating the mechanisms and functions of metalloenzymes in cofactor and natural product biosynthesis. The...
- Federal Project Grant Award Summary Princeton University's Office of Research and Project Administration has been awarded $1,968,575 through the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) for a project titled "Computational Approaches for Elucidating Proteomes and Interactomes." The award, effective September 15, 2025, with completion scheduled for August 31, 2029, supports the development of advanced...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $125,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2026, through May 31, 2028. The award funds investigator-initiated research examining the role of RNA editing in organizing the cytoplasm. The research will identify novel RNA editing sites across the...
- Federal Grant Award Summary Funding Agency and Program: The National Institute of General Medical Sciences (NIGMS) awarded this Project Grant under the Biomedical Research and Research Training program (CFDA 93.859) on May 13, 2026, with a total obligation of $125,000.00 and completion date of April 30, 2028. Products and Services Delivered: This award supports a postdoctoral research project at Columbia University's Health Sciences Division focused on developing an integrated computational...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $474,507 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026 through March 31, 2031. The award funds fundamental research into cell signaling through O-linked glycosylation, specifically investigating O-linked β-N-acetylglucosamine (O-GlcNAc), a ubiquitous...
- Federal Grant Award Summary Duke University's Office of Research Administration received a $523,255 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded on March 12, 2026, with completion expected by February 28, 2031. The research project, titled "Mechanism, Regulation and Impact of Transposon Activation," delivers fundamental scientific research investigating the regulatory...
- Federal Project Grant Award Summary Duke University's Office of Research Administration received a $446,410 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective April 1, 2026, through March 31, 2030. The award funds the development and validation of novel statistical methodologies designed to identify disease subtypes through analysis of heterogeneous patient data. Specifically, the...
- Federal Grant Award Summary Duke University received a $829,968 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective August 1, 2025 through May 31, 2030. The grant supports the development of novel amination methods and strategies for chemical synthesis aimed at accelerating the creation of nitrogen-containing molecules critical to biomedical research and drug discovery. The research...
Duke University's Office of Research Administration received a $375,996 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective July 1, 2026 through June 30, 2030. The award funds research to advance protein language models (PLMs)—computational tools that learn task-specific representations mapping protein sequences to functional outcomes. The research deliverables address three critical limitations in current PLMs: developing length-invariant generative representations that systematically explore insertions, deletions, and substitutions; introducing reverse distillation techniques to enable reliable scaling of large models through small-model guidance; and building modular aggregation layers that retain family-specific constraints while producing portable, task-aware sequence representations for classification and regression tasks. The funded research will produce practical applications demonstrating these methodological advances across diverse protein engineering tasks, including optimizing mastoparan variants for antimicrobial potency with reduced cytotoxicity, improving fluorescent protein brightness through accurate mutational-effect modeling, and mapping epistatic rules governing viral immune escape in influenza. Upon completion, the project will deliver powerful, generalizable protein representations capable of handling complex mutations and producing well-calibrated predictions for protein design and prioritization across multiple biological domains.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $376.0k | 6/23/26 |